First company receives FDA violation notice for ClinicalTrials.gov submission omission

Published date29 April 2021
Subject MatterFDA,FDCA,Public Health Service Act,Enforcement Actions,Clinical Trials,Filing Requirements,Noncompliance,Pharmaceutical Industry,Statutory Violations,Regulatory Requirements
AuthorHeidi Forster Gertner,Robert Church,Blake Wilson,Bert Lao,David Horowitz
Law FirmHogan Lovells

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT